Search

Your search keyword '"Castelletti S"' showing total 159 results

Search Constraints

Start Over You searched for: Author "Castelletti S" Remove constraint Author: "Castelletti S" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
159 results on '"Castelletti S"'

Search Results

1. Candidacy and long-term outcomes of subcutaneous implantable cardioverter-defibrillators in current practice in patients with hypertrophic cardiomyopathy

2. Standardised assessment of evidence supporting the adoption of mobile health solutions: A Clinical Consensus Statement of the ESC Regulatory Affairs Committee

3. From the phenotype to precision medicine: An update on the cardiomyopathies diagnostic workflow

4. Corrigendum to “Molecular genetic testing in athletes: Why and when a position statement from the Italian Society of Sports Cardiology” [International Journal of Cardiology Volume 364, 1 October 2022, Pages 169–177]. (International Journal of Cardiology (2022) 364 (169–177), (S016752732200818X), (10.1016/j.ijcard.2022.05.071))

5. Left Cardiac Sympathetic Denervation for Long QT Syndrome: 50 Years’ Experience Provides Guidance for Management

10. Use of artificial intelligence to automatically predict the optimal patient-specific inversion time for late gadolinium enhancement imaging. Tool development and clinical validation

11. Circadian and Seasonal Pattern of Arrhythmic Events in Arrhythmogenic Cardiomyopathy Patients

12. Improved diagnostic accuracy for apical hypertrophic cardiomyopathy

13. Estimating the Posttest Probability of Long QT Syndrome Diagnosis for Rare KCNH2 Variants

14. Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls

15. Mutation location and IKsregulation in the arrhythmic risk of long QT syndrome type 1: The importance of the KCNQ1 S6 region

16. Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort

17. A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK)

19. SCN5A mutation type and a genetic risk score associate variably with brugada syndrome phenotype in SCN5A families

20. Abnormal myocardial expression of SAP97 is associated with arrhythmogenic risk

21. Partial Pericardial Agenesis Mimicking Arrhythmogenic Right Ventricular Cardiomyopathy

22. Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy

23. Indications and utility of cardiac genetic testing in athletes

24. Author Correction: Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility (Nature Genetics, (2022), 54, 3, (232-239), 10.1038/s41588-021-01007-6)

25. Molecular genetic testing in athletes: Why and when a position statement from the Italian Society of Sports Cardiology

26. Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility

27. Indications and utility of cardiac genetic testing in athletes

28. Effective Study: Development and Application of a Question-Driven, Time-Effective Cardiac Magnetic Resonance Scanning Protocol

31. Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

32. Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data

33. Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls

34. Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort

35. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

36. Long and Short QT syndromes.

37. Exercise Training-Induced Repolarization Abnormalities Masquerading as Congenital Long QT Syndrome

39. The Membership Committee of the ESC

40. Risk score for the exclusion of arrhythmic events in arrhythmogenic right ventricular cardiomyopathy at first presentation

41. Topografie a confronto: Piuro 1618 – 2018

42. From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2

43. L'Italia come modello per l'Europa e per il mondo nelle politiche sanitarie per il trattamento dell'epatite cronica da HCV

44. Advanced Arrhythmogenic Cardiomyopathy in Former Marathon Runner

45. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1

46. The genetics underlying idiopathic ventricular fibrillation: A special role for catecholaminergic polymorphic ventricular tachycardia?

47. Late gadolinium enhancement in Brugada syndrome: A marker for subtle underlying cardiomyopathy?

48. P297Cardiac sympathetic denervation: evolving technique, expanding indications

Catalog

Books, media, physical & digital resources